Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVA-001 selective treatment after EVA-001-02 completion
jRCT2053240149Active, not recruiting
- Sponsor
- MEDIPOST
- Start
- Jun 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of EVA-001 in knee osteoarthritis (OA), sponsored by MEDIPOST. Primary endpoint: Incidence of adverse events. Started Jun 2024; status: active, not recruiting.
02
Drugs
EVA-001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2053240149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2053240149.